Photonics Spectra BioPhotonics Vision Spectra Photonics Showcase Photonics Buyers' Guide Photonics Handbook Photonics Dictionary Newsletters Bookstore
Latest News Latest Products Features All Things Photonics Podcast
Marketplace Supplier Search Product Search Career Center
Webinars Photonics Media Virtual Events Industry Events Calendar
White Papers Videos Contribute an Article Suggest a Webinar Submit a Press Release Subscribe Advertise Become a Member


Abbott Boosts Holdings in SpectRx

NORCROSS, Ga., Sept. 7 -- SpectRx said that Abbott Laboratories Inc. will buy an additional $1 million of its stock as part of a milestone payment, but it agreed to postpone payment of another $1 million. The milestone payments are part of an agreement to commercialize SpectRx's diabetes monitoring device. The SpectRx device is worn on top of the skin and measures glucose levels by using a laser to create microscopic holes, or micropores, and draw samples of interstitial fluid.

Norcross, Georgia-based SpectRx said the $1 million stock purchase will increase medical device maker Abbott's common stock ownership in SpectRx to about 5.9 percent. SpectRx said it expects payment of the remaining $1 million before the end of 2002. The second payment and a portion of the first payment are subject SpectRx maintaining its rights to sublicense to Abbott certain technologies it licensed from Altea Development Corp. SpectRx and Altea are currently in arbitration related to their license agreement.

Explore related content from Photonics Media




LATEST NEWS

Terms & Conditions Privacy Policy About Us Contact Us

©2024 Photonics Media